Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,246 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07161245Recruiting
Fatigue relief study for primary biliary cholangitis
This trial tests a program of exercise, nutrition, and education to help reduce fatigue in people with primary biliary cholangitis. It aims to see if this program can improve energy and quality of life.
Barcelona, BarcelonaAges 18–80 - NCT07160231RecruitingPhase 4
Lowering dose of JAK inhibitors for rheumatoid arthritis or psoriatic arthritis
This trial tests if reducing the dose of a JAK inhibitor can keep your inflammatory arthritis under control. If you have rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis and are in a stable remission, you may be able to take a lower dose.
Nijmegen, GelderlandAges 16 years+ - NCT07164495Recruiting
Foot pressure risks during walking in diabetes
This study looks at why people with type 2 diabetes develop high pressure on the bottom of their feet while walking. The goal is to find risk factors that may lead to foot problems, so doctors can help prevent them.
Taichung, TaiwanAges 18 years+ - NCT07162298RecruitingPhase 2
Dragon boat racing vs. home exercise for breast cancer patients
This study compares dragon boat racing with unsupervised home exercise to see which better improves physical function and quality of life in breast cancer patients. It may help you become more active and feel better during recovery.
HangzhouAges 18–75 - NCT07158307Enrolling by invitation
Studying a new balloon treatment for small heart arteries
This trial tests a special balloon coated with medicine to treat blocked small arteries in the heart. It may help people who have new blockages and are getting a procedure to open those arteries.
UlsanAges 19 years+ - NCT07164378Recruiting
Study of an implant for vision loss from advanced AMD
This trial tests a small telescope implant for people with advanced age-related macular degeneration (AMD) in both eyes. It aims to improve central vision in the eye where the implant is placed.
MarseilleAges 55 years+ - NCT07159087Enrolling by invitation
New drug balloon for re-narrowed stents
This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.
Gyeonggi-doAges 19 years+ - NCT07157033RecruitingPhase 1/Phase 2
Testing XER-001 with radiation for advanced pancreatic cancer
This trial tests a new way to deliver a drug called amifostine (XER-001) alongside intense radiation therapy (SBRT) for people with locally advanced pancreatic cancer that can't be surgically removed. The goal is to see if it's safe and effective at protecting healthy tissue while targeting the tumor.
Duarte, CaliforniaAges 18 years+ - NCT07158775RecruitingPhase 1/Phase 2
BS01 gene therapy for dry age-related macular degeneration
This trial tests a new gene therapy, BS01, given as an eye injection. It is for people with advanced dry age-related macular degeneration (AMD) that has caused geographic atrophy—damage to the central part of the retina. The study aims to see if the treatment is safe and can help slow vision loss.
Edison, New JerseyAges 50–85 - NCT07156773RecruitingPhase 2
Nasal spray for Parkinson's off episodes
This study tests a new nasal spray called XJN010 for people with Parkinson's who have 'off' episodes—times when their regular medication wears off and symptoms come back. The goal is to see if the spray can safely and effectively help during those periods.
Guangzhou, GuangdongAges 30–85 - NCT07163234Recruiting
Safety of a groin artery tube for heart surgery
This study is testing a special tube (cannula) placed in the groin artery during heart surgery to connect a heart-lung machine. It's for people who are scheduled for planned heart surgery and may be helped by this refined device.
MassyAges 18 years+ - NCT07157007RecruitingPhase 2
Testing a New COVID-19 Drug for Mild to Moderate Cases
This trial tests a new drug, ratutrelvir, for people with mild to moderate COVID-19. It aims to find a safe and effective dose to help you feel better faster.
Charlestown, New South WalesAges 18 years+ - NCT07156669Recruiting
Safety and Performance of Novalung ECMO Kit and Xenios 2.0
This study is testing how well a special ECMO device (Novalung ultimate kit with Xenios 2.0) works for adults in the hospital and during ground transport. If you already need ECMO with this specific device, you may be able to join.
Erfurt, BavariaAges 18 years+ - NCT06591793RecruitingPhase 1/Phase 2
Gene therapy for Usher syndrome type 1B vision loss
This trial tests an experimental gene therapy given as an injection under the retina. It aims to slow or stop vision loss in people with Usher syndrome type 1B, a rare genetic condition that causes both hearing and vision problems.
NaplesAges 18–50 - NCT05263960RecruitingPhase 1/Phase 2
CM350 drug study for advanced solid tumors
This trial tests CM350 in people with advanced solid cancers that are hard to treat with standard options. It may help by finding a safe dose and whether the drug can work against these cancers.
Chengdu, SichuanAges 18–75 - NCT06618963RecruitingPhase 4
Omalizumab for food allergy skin effects
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
Denver, ColoradoAges 1–55 - NCT06643585RecruitingPhase 3
Comparing T-DXd to standard therapy for molecular relapse in early breast cancer
This trial compares a new drug called Trastuzumab-Deruxtecan (T-DXd) to standard treatment for people with early breast cancer whose cancer has come back at a molecular level (detected by a blood test) but hasn't spread to other parts of the body. The goal is to see if T-DXd can prevent the cancer from returning.
UlmAges 18–75 - NCT06692296Recruiting
Balance training with a stabilometric platform for Friedreich's ataxia
This trial tests if a special platform that measures balance can help people with Friedreich's ataxia stand more steadily. If you have Friedreich's ataxia, can walk at least 10 metres and stand without support, you may be eligible.
Pieve di Soligo, VenetoAges 14 years+ - NCT06908343Recruiting
Expectations and Distress in Mental Health Patients and Their Therapists
This study looks at how your expectations about therapy affect your distress and how your therapist's expectations play a role. It may help improve treatment for people like you at Shalvata.
IsraelAges Any age - NCT06867926Recruiting
Heart rehab and its effect on DNA and inflammation
This study looks at whether a cardiac rehabilitation program can reduce DNA damage and inflammation in people with coronary artery disease. It may help patients understand how exercise and lifestyle changes can affect their heart health at a cellular level.
KayseriAges 18–65 - NCT06921746Recruiting
Urinary microbiome and metabolism changes in overactive bladder treatment
This study looks at how the bacteria and chemicals in your urine change when women receive treatment for overactive bladder. It may help researchers understand why some treatments work better for some people.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT06222164Recruiting
Using leftover patient samples for research
This study uses leftover blood, bone marrow, or tissue samples that were already sent to a specific lab (LabPMM) for testing. Researchers want to study these samples to learn more about diseases and improve future tests for patients.
San Diego, CaliforniaAges 18 years+ - NCT06801171Recruiting
Boosting resilience for people with mild memory problems
This study tests a program that combines gentle activities (like meditation, yoga, or tai chi) to help people with mild memory problems feel stronger and more able to handle stress. It is for people aged 60 and older who have mild cognitive issues but are not in therapy or already doing similar practices.
NiceAges 60 years+ - NCT06765499Recruiting
Silkworm pupa powder for nutrition and frailty in motor neuron disease
This trial tests whether silkworm pupa powder can improve nutrition and reduce frailty in people with motor neuron disease (like ALS). It looks for volunteers who are frail, have a confirmed diagnosis, and are willing to provide blood, stool, and urine samples.
Hangzhou, ZhejiangAges 18–80
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,246 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.